Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma

INTRODUCTION: Melphalan, as a bifunctional alkylating agent has been shown to be selectively efficient in BRCA-deficient case reports of epithelial ovarian cancer (EOC). The clinical benefit of melphalan on unselected platinum-resistant EOC population and stratified by BRCA status has not been clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Conteduca, Vincenza, Scarpi, Emanuela, Farolfi, Alberto, Brighi, Nicole, Rossi, Lorena, Gurioli, Giorgia, Lolli, Cristian, Schepisi, Giuseppe, Bleve, Sara, Gianni, Caterina, Virga, Alessandra, Altavilla, Amelia, Burgio, Salvatore Luca, Menna, Cecilia, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336462/
https://www.ncbi.nlm.nih.gov/pubmed/34367999
http://dx.doi.org/10.3389/fonc.2021.716467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336462/
https://www.ncbi.nlm.nih.gov/pubmed/34367999
http://dx.doi.org/10.3389/fonc.2021.716467

Ejemplares similares